NCT01667445View on ClinicalTrials.gov

Evaluation of the Use of Spinal Epimorph in Total Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Post-operative PainOsteoarthritis
Interventions
DRUG

Epimorph

Patient to receive 150ug of Epimorph with Spinal anaesthetic. Injection Cocktail includes: 10mg Morphine, 30mg Ketorolac, 3.5ug/ml (385ug total) of Ropivicaine, 2.5ug /ml (275ug total) Epinephrine with the remainder of the solution made of Normal Saline to a total volume of 110ml.

DRUG

Spinal analgesia

Patient to receive only Spinal anaesthetic (NO EPIMORPH). Injection Cocktail includes: 10mg Morphine, 30mg Ketorolac, 3.5ug/ml (385ug total) of Ropivicaine, 2.5ug /ml (275ug total) Epinephrine with the remainder of the solution made of Normal Saline to a total volume of 110ml.

Trial Locations (1)

N6A 5A5

University Hospital, London Health Sciences Centre, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT01667445 - Evaluation of the Use of Spinal Epimorph in Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter